Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
about
Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.Mechanism underlying renal failure caused by pathogenic Candida albicans infection.In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis.Assessment of the paradoxical effect of caspofungin in therapy of candidiasisSaccharomyces as a vaccine against systemic candidiasis.
P2860
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@ast
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@en
type
label
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@ast
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@en
prefLabel
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@ast
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@en
P356
P1476
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
@en
P2093
Clemons KV
Stevens DA
P304
P356
10.1093/JAC/47.2.183
P407
P577
2001-02-01T00:00:00Z